Evidence map›Paper›PMID 20627933›Full record

ArticleDiabetes2010

The medial amygdalar nucleus: a novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia.

Ligang Zhou, Nina Podolsky, Zhen Sang, Yuyan Ding, Xiaoning Fan, Qingchun Tong, Barry E Levin, Rory J McCrimmon

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Brain-Body Communication in Glucose Metabolism.Advances in experimental medicine and biology · 2025
    Review
  7. Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes.Diabetic medicine : a journal of the British Diabetic Association · 2022
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Remote control of glucose-sensing neurons to analyze glucose metabolism.American journal of physiology. Endocrinology and metabolism · 2018
    Review
  18. Article
  19. Glucose-Sensing in the Reward System.Frontiers in neuroscience · 2017
    Review
  20. Insights into the role of neuronal glucokinase.American journal of physiology. Endocrinology and metabolism · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ligang ZhouDepartment of Internal Medicine, Yale University, New Haven, Connecticut, USA.
Nina Podolsky
Zhen Sang
Yuyan Ding
Xiaoning Fan
Qingchun Tong
Barry E Levin
Rory J McCrimmon
Yale University · USEast Orange VA Medical Center · USBeth Israel Deaconess Medical Center · USBiomedical Research Institute · US

Funding

BRAIN GLUCOSENSING NEURONS IN HEALTH AND DIABETESR01DK053181 · NIDDK · VETERANS BIOMEDICAL RESEARCH INSTITUTE · PI LEVIN, BARRY E · 1998 to 2014
$5.6M
Role of AMPK in hypoglycemia-sensing in the VMHR01DK069831 · NIDDK · YALE UNIVERSITY · PI MCCRIMMON, RORY J · 2004 to 2008
$1.4M
NIDDK NIH HHS DK-069831NIDDK NIH HHS DK-53181NIDDK NIH HHS R01 DK053181NIDDK NIH HHS R01 DK069831
6 · The paper itself

Abstract

objectiveTo determine whether the medial amygdalar nucleus (MAN) represents a novel brain glucose-sensing region involved in the detection of hypoglycemia and generation of a counterregulatory hormone response. RESEARCH DESIGN AND

methodsFura-2 calcium imaging was used to assess glucose responsivity in neurons isolated from the MAN and single-cell real-time reverse transcription PCR used to examine gene expression within glucose-responsive neurons. In vivo studies with local MAN perfusion of the glucoprivic agent, 2-deoxyglucose (2-DG), under normal and hypoglycemic conditions and also after MAN lesioning with ibotenic acid, were used to examine the functional role of MAN glucose sensors. In addition, retrograde neuronal tracer studies were used to examine reciprocal pathways between the MAN and the ventromedial hypothalamus (VMH).

resultsThe MAN contains a population of glucose-sensing neurons (13.5%), which express glucokinase, and the selective urocortin 3 (UCN3) receptor CRH-R2, but not UCN3 itself. Lesioning the MAN suppressed, whereas 2-DG infusion amplified, the counterregulatory response to hyperinsulinemic hypoglycemia in vivo. However, 2-DG infusion to the MAN or VMH under normoglycemic conditions had no systemic effect. The VMH is innervated by UCN3 neurons that arise mainly from the MAN, and ∼1/3 of MAN UCN3 neurons are active during mild hypoglycemia.

conclusionsThe MAN represents a novel limbic glucose-sensing region that contains characteristic glucokinase-expressing glucose-sensing neurons that respond directly to manipulations of glucose availability both in vitro and in vivo. Moreover, UCN3 neurons may provide feedback inhibitory regulation of the counterregulatory response through actions within the VMH and the MAN.

Indexed as

AmygdalaAnimalsAwarenessCalciumCarotid Artery, InternalDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Excitatory Amino Acid AgonistsGene Expression RegulationGlucokinaseGlucoseHomeostasisHumansHyperinsulinismHypoglycemiaIbotenic AcidCalciumExcitatory Amino Acid AgonistsGlucokinaseGlucoseIbotenic Acid

Identifiers

PMID20627933
PMCPMC3279559
OpenAlexW2165161550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.